PROGRAM CHAIR
Tiffany N. Tanaka, MD
Associate Professor
UC San Diego Moores Cancer Center
San Diego, CA
PROGRAM OVERVIEW
This enduring activity is designed to focus on the care of veteran patients with lower-risk myelodysplastic syndrome. This enduring VAVISN series, simulcasts with simulations, and the subsequent enduring replay will help healthcare professionals identify best practices for early diagnosis of myelodysplastic syndrome and review risk stratification and treatment for managing lower-risk myelodysplastic syndrome according to recent guidelines. This program will also outline the clinical data to support the best frontline and second-line therapeutic options for lower-risk myelodysplastic syndrome.
TARGET AUDIENCE
This program is designed to address the educational needs of the multidisciplinary hematology-oncology team within the Department of Veterans Affairs Health System, including hematologists, pathologists, nurses, and other multidisciplinary healthcare professionals working together to address the needs of veteran patients with lower-risk myelodysplastic syndrome.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Identify diagnostic best practices to facilitate early identification of myelodysplastic syndrome
- Incorporate appropriate application of guideline-informed risk stratification and treatment into the management of lower-risk myelodysplastic syndrome
- Interpret current clinical data informing the selection of frontline and second-line therapeutic options in the management of lower-risk myelodysplastic syndrome
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Tiffany N. Tanaka, MD | Discloses serving as a consultant for Bristol Myers Squibb, Gilead Sciences, Rigel, and Servier. She also provides contracted research for Function Oncology. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer-reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP of Educational Development for Med Learning Group, has nothing to disclose.
- Minal Mulye, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- Dominique Barton, B.S. BSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lauren Bartunek, Program Manager for Med Learning Group, has nothing to disclose.
- Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: September 16, 2024
EXPIRATION DATE: September 16, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
